FCN · XBRL financial data
Fti Consulting financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (FCN's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 2,461 | 2,776 | 3,029 | 3,489 | 3,699 | 3,789 |
| Revenue from contracts with customers | 2,461 | 2,776 | 3,029 | 3,489 | 3,699 | 3,789 |
| Cost of revenue | 1,673 | 1,916 | 2,066 | 2,354 | 2,517 | 2,571 |
| Gross profit | — | — | 963 | 1,135 | 1,182 | 1,217 |
| Selling, general and administrative | 488 | 538 | 641 | 751 | 822 | 800 |
| Operating income (loss) | 283 | 312 | 304 | 378 | 347 | 389 |
| Interest expense | 20 | 20 | 10 | 14 | 7 | 21 |
| Other income (expense) | (0) | 0 | (1) | (1) | 1 | 1 |
| Income tax expense (benefit) | 52 | 63 | 62 | 83 | 71 | 100 |
| Net income (loss) | 211 | 235 | 236 | 275 | 280 | 271 |
| Earnings per share, basic USD per share | 5.92 | 7.02 | 6.99 | 8.10 | 7.96 | 8.33 |
| Earnings per share, diluted USD per share | 5.67 | 6.65 | 6.58 | 7.71 | 7.81 | 8.24 |
| Weighted average shares, basic millions of shares | 36 | 33 | 34 | 34 | 35 | 33 |
| Weighted average shares, diluted millions of shares | 37 | 35 | 36 | 36 | 36 | 33 |
Balance sheet
CSVFiscal years (FCN's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 295 | 494 | 492 | 303 | 660 | 265 |
| Short-term investments | — | — | 0 | 25 | 0 | — |
| Accounts receivable | 711 | 754 | 896 | 1,102 | 1,020 | 1,038 |
| Prepaid and other current assets | 88 | 91 | 95 | 119 | 94 | 127 |
| Total current assets | 1,130 | 1,370 | 1,511 | 1,555 | 1,820 | 1,518 |
| Property and equipment, net | 102 | 142 | 153 | 160 | 150 | 169 |
| Right-of-use asset | 157 | 216 | 204 | 209 | 198 | 201 |
| Goodwill | 1,235 | 1,233 | 1,228 | 1,235 | 1,227 | 1,243 |
| Total assets | 2,777 | 3,101 | 3,241 | 3,326 | 3,597 | 3,491 |
| Accounts payable | 13 | 16 | 20 | 22 | 26 | 15 |
| Accrued liabilities | 65 | 62 | 65 | 75 | 83 | 98 |
| Current portion of long-term debt | 0 | 0 | 0 | 0 | — | 0 |
| Total current liabilities | 670 | 718 | 769 | 893 | 932 | 975 |
| Long-term debt | 286 | 297 | 315 | 0 | 0 | 365 |
| Lease liability, non-current | 162 | 236 | 222 | 224 | 208 | 225 |
| Total liabilities | 1,377 | 1,518 | 1,560 | 1,344 | 1,339 | 1,757 |
| Retained earnings | 1,506 | 1,698 | 1,858 | 2,115 | 2,395 | 1,863 |
| Total stockholders' equity | 1,400 | 1,583 | 1,682 | 1,981 | 2,258 | 1,734 |
| Total liabilities and equity | 2,777 | 3,101 | 3,241 | 3,326 | 3,597 | 3,491 |
| Common shares outstanding (cover page) millions of shares | 34 | 34 | 34 | 36 | 36 | 31 |
Cash flows
CSVFiscal years (FCN's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 211 | 235 | 236 | 275 | 280 | 271 |
| Stock-based compensation | 23 | 23 | 25 | 30 | 38 | 39 |
| Net cash from operating activities | 327 | 355 | 189 | 224 | 395 | 152 |
| Purchases of property and equipment | 35 | 69 | 53 | 49 | 35 | 59 |
| Net cash from investing activities | (60) | (79) | (60) | (74) | (10) | (59) |
| Share repurchases | 354 | 46 | 85 | 21 | 10 | 859 |
| Repayments of long-term debt | 0 | — | — | — | — | — |
| Net cash from financing activities | (360) | (62) | (106) | (355) | (15) | (510) |
| Net change in cash | (74) | 200 | (3) | (188) | 357 | (395) |
Compare with peers
SIC 8742 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8742 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Fti Consulting | 88 | 1,013 | 190* | 27.3M | — | 10-QSep 30, 2026 |
| Exponent | 67 | 172 | 31* | 47.5M | — | 10-QJul 3, 2026 |
| Genpact | 517 | 1,343 | 72* | 168.0M | — | 10-QJun 30, 2026 |
| Huron Consulting Group | 26 | 491 | 57* | 15.8M | — | 10-QSep 30, 2026 |
| Premier | 43 | 240 | 16 | 82.7M | — | 10-QSep 30, 2025 |
| Booz Allen Hamilton Holding | 334 | 2,778 | 294* | 118.6M | — | 10-QSep 30, 2026 |
| ICF International | 4.6 | 474 | 100* | 17.9M | — | 10-QJun 30, 2026 |
| Evolent Health | 116 | 653 | (9.3)* | 113.1M | 12.4 quarters | 10-QJun 30, 2026 |
| Astrana Health | 401 | 973 | 33* | 55.7M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.